Piper Jaffray Expands Medical Technology Research Expertise; Hires Suraj Kalia
13 February 2007 - 4:10AM
PR Newswire (US)
NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- In an effort to provide
clients the best proprietary and in-depth research analysis in the
medical technology sector, Piper Jaffray announces it has hired
Suraj Kalia to join the Piper Jaffray Investment Research team.
Kalia will broaden the firm's coverage of the medical technology
sector. He will be based in the firm's New York office. Kalia has
more than 15 years of experience working in the financial and
health care industries. Most recently, he was a senior medical
device analyst at Rodman & Renshaw, LLC in New York. He was
ranked No. 1 by Forbes.com/Starmine and No. 5 in the 2005 Wall
Street Journal's "Best on the Street" survey in the medical devices
sector. In his career, he also spent seven years as project and
team manager of the mergers and acquisitions practice at Entegris
Inc., a semiconductor company. Additionally, he worked in
investment banking for Tata Capital in Bombay, India, for four
years. "Extending our research product offering in the medical
technology sector will offer our clients additional proprietary and
in-depth analysis," said Joel Denney, head of Investment Research.
"Suraj's deep health care, engineering and financial knowledge has
brought him to the top research rankings in the medical technology
sector. We look forward to having his capabilities included on our
health care team." Kalia has a bachelor's degree in chemical
engineering from the Indian Institute of Technology in Bombay,
India, a master's degree in chemical engineering at Stevens
Institute of Technology in Hoboken, N.J. and a master's of business
administration degree at the University of St. Thomas in
Minneapolis. He also holds the Chartered Financial Analyst (CFA)
designation. About Piper Jaffray Piper Jaffray Companies is a
leading, international middle market investment bank and
institutional securities firm, serving the needs of middle market
corporations, private equity groups, public entities, nonprofit
clients and institutional investors. Founded in 1895, Piper Jaffray
provides a comprehensive set of products and services, including
equity and debt capital markets products; public finance services;
mergers and acquisitions advisory services; high-yield and
structured products; institutional equity and fixed- income sales
and trading; and equity and high-yield research. With headquarters
in Minneapolis, Piper Jaffray has 25 offices across the United
States and international locations in London, and Shanghai. The
firm's UK operating subsidiary, Piper Jaffray Ltd., is authorized
and regulated by the Financial Services Authority and is a member
of the London Stock Exchange. Piper Jaffray & Co. is the firm's
principal operating subsidiary. (NYSE:PJC) (
http://www.piperjaffray.com/ ) Since 1895. Member SIPC and NYSE.
DATASOURCE: Piper Jaffray CONTACT: Susan Beatty, Media Relations,
of Piper Jaffray & Co., +1-612-303-5680 Web site:
http://www.piperjaffray.com/
Copyright
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Piper Jaffray Companies (New York Stock Exchange): 0 recent articles
More Piper Jaffray Cos News Articles